Correlation Between Neurocrine Biosciences and Ironwood Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Ironwood Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Ironwood Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Ironwood Pharmaceuticals, you can compare the effects of market volatilities on Neurocrine Biosciences and Ironwood Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Ironwood Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Ironwood Pharmaceuticals.
Diversification Opportunities for Neurocrine Biosciences and Ironwood Pharmaceuticals
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neurocrine and Ironwood is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Ironwood Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ironwood Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Ironwood Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ironwood Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Ironwood Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Ironwood Pharmaceuticals
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.41 times more return on investment than Ironwood Pharmaceuticals. However, Neurocrine Biosciences is 2.41 times less risky than Ironwood Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Ironwood Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 9,444 in Neurocrine Biosciences on November 1, 2024 and sell it today you would earn a total of 5,885 from holding Neurocrine Biosciences or generate 62.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Ironwood Pharmaceuticals
Performance |
| Timeline |
| Neurocrine Biosciences |
| Ironwood Pharmaceuticals |
Neurocrine Biosciences and Ironwood Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Ironwood Pharmaceuticals
The main advantage of trading using opposite Neurocrine Biosciences and Ironwood Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Ironwood Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ironwood Pharmaceuticals will offset losses from the drop in Ironwood Pharmaceuticals' long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Ironwood Pharmaceuticals vs. Neurocrine Biosciences | Ironwood Pharmaceuticals vs. Amphastar P | Ironwood Pharmaceuticals vs. Collegium Pharmaceutical | Ironwood Pharmaceuticals vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |